Surgery Days Sales Outstanding from 2010 to 2024

SGRY Stock  USD 23.84  0.43  1.84%   
Surgery Partners Days Sales Outstanding yearly trend continues to be fairly stable with very little volatility. Days Sales Outstanding is likely to outpace its year average in 2024. During the period from 2010 to 2024, Surgery Partners Days Sales Outstanding regression line of annual values had r-squared of  0.11 and arithmetic mean of  78.40. View All Fundamentals
 
Days Sales Outstanding  
First Reported
2010-12-31
Previous Quarter
66.04673204
Current Value
85.05
Quarterly Volatility
18.07063247
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Surgery Partners financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Surgery Partners' main balance sheet or income statement drivers, such as Depreciation And Amortization of 80.6 M, Interest Expense of 148.4 M or Selling General Administrative of 80.8 M, as well as many indicators such as Price To Sales Ratio of 1.52, Dividend Yield of 0.0014 or PTB Ratio of 2.12. Surgery financial statements analysis is a perfect complement when working with Surgery Partners Valuation or Volatility modules.
  
Check out the analysis of Surgery Partners Correlation against competitors.
For more information on how to buy Surgery Stock please use our How to Invest in Surgery Partners guide.

Latest Surgery Partners' Days Sales Outstanding Growth Pattern

Below is the plot of the Days Sales Outstanding of Surgery Partners over the last few years. It is Surgery Partners' Days Sales Outstanding historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Surgery Partners' overall financial position and show how it may be relating to other accounts over time.
Days Sales Outstanding10 Years Trend
Slightly volatile
   Days Sales Outstanding   
       Timeline  

Surgery Days Sales Outstanding Regression Statistics

Arithmetic Mean78.40
Geometric Mean76.94
Coefficient Of Variation23.05
Mean Deviation10.18
Median75.00
Standard Deviation18.07
Sample Variance326.55
Range73.9064
R-Value(0.33)
Mean Square Error313.61
R-Squared0.11
Significance0.23
Slope(1.33)
Total Sum of Squares4,572

Surgery Days Sales Outstanding History

2024 85.05
2023 66.05
2022 65.59
2021 70.57
2020 75.0
2019 65.15
2018 65.14

About Surgery Partners Financial Statements

Surgery Partners investors use historical fundamental indicators, such as Surgery Partners' Days Sales Outstanding, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Surgery Partners. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Days Sales Outstanding 66.05  85.05 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Surgery Stock Analysis

When running Surgery Partners' price analysis, check to measure Surgery Partners' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Surgery Partners is operating at the current time. Most of Surgery Partners' value examination focuses on studying past and present price action to predict the probability of Surgery Partners' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Surgery Partners' price. Additionally, you may evaluate how the addition of Surgery Partners to your portfolios can decrease your overall portfolio volatility.